data_2n16_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n16 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.582 0.706 . . . . 74.140000000000001 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.140000000000001 112.344 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.399999999999999 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 74.120000000000005 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.120000000000005 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 75.140000000000001 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.93 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 73.450000000000003 111.179 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.209999999999994 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.030000000000001 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.129999999999995 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.972 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 74.019999999999996 112.317 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.099999999999994 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.109999999999999 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.873 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 74.400000000000006 111.132 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.119999999999997 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 74.530000000000001 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.876 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.609 0.718 . . . . 75.329999999999998 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.530000000000001 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.842 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.530000000000001 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 75.450000000000003 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 75.420000000000002 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 72.140000000000001 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.530000000000001 110.904 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.591 0.71 . . . . 71.340000000000003 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.372 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 55.549999999999997 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.450000000000003 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.549999999999997 110.921 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.478 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.400000000000006 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.869 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.299999999999997 111.133 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.140000000000001 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.349999999999994 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 73.450000000000003 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 63.409999999999997 112.319 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 50.5 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 72.420000000000002 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 70.430000000000007 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.891 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 111.118 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 71.439999999999998 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 73.209999999999994 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 70.319999999999993 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.9 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.593 0.711 . . . . 72.420000000000002 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.450000000000003 112.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.319999999999993 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 70.209999999999994 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 74.150000000000006 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 111.137 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.230000000000004 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.540000000000006 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.400000000000006 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.865 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.604 0.716 . . . . 75.409999999999997 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.239999999999995 112.343 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.540000000000006 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 75.219999999999999 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 72.109999999999999 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 75.030000000000001 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.340000000000003 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 73.040000000000006 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.209999999999994 110.887 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.571 0.7 . . . . 72.540000000000006 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.200000000000003 112.371 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.329999999999998 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 75.400000000000006 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.899 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.349999999999994 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.219999999999999 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.439999999999998 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 64.340000000000003 110.87 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.030000000000001 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.209999999999994 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.613 0.72 . . . . 73.299999999999997 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 74.519999999999996 112.328 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 74.019999999999996 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 70.5 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.409999999999997 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 75.0 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.310000000000002 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.540000000000006 111.102 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.420000000000002 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 72.099999999999994 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.967 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.577 0.703 . . . . 64.219999999999999 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.120000000000005 112.325 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.409999999999997 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.150000000000006 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 72.109999999999999 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.120000000000005 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 74.409999999999997 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.409999999999997 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.111 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.209999999999994 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 74.430000000000007 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 110.951 -179.911 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 9.1 tpt -61.51 115.99 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.873 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.33 160.56 54.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 74.140000000000001 110.851 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.140000000000001 112.344 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.399999999999999 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 74.120000000000005 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 72.439999999999998 110.911 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.120000000000005 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 75.140000000000001 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.93 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 73.450000000000003 111.179 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.209999999999994 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.030000000000001 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.129999999999995 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -53.61 39.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.972 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.5 48.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 74.329999999999998 111.108 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 61.14 47.62 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.019999999999996 110.905 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -104.93 170.33 7.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.219999999999999 110.877 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 72.430000000000007 110.915 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 72.129999999999995 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.3 mmm -93.44 -57.33 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 73.329999999999998 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -73.77 160.56 81.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 110.869 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 74.019999999999996 112.317 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.099999999999994 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.109999999999999 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 74.230000000000004 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.873 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 74.400000000000006 111.132 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.119999999999997 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 74.530000000000001 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -51.02 59.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.876 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -54.46 -37.32 65.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.219999999999999 111.071 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? 57.5 27.89 14.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 63.340000000000003 110.882 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.3 mtpt -56.66 173.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.933 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 52.340000000000003 110.896 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 72.430000000000007 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.05 148.79 51.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 63.210000000000001 110.849 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.0 160.58 1.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.718 . . . . 75.329999999999998 110.85 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.530000000000001 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.842 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 71.329999999999998 110.889 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 73.530000000000001 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 75.450000000000003 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 75.420000000000002 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 73.299999999999997 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 72.140000000000001 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.94 -48.23 64.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.530000000000001 110.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.9 47.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 74.519999999999996 111.083 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 130.7 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 71.329999999999998 110.933 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -104.51 153.73 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 73.5 110.93 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 74.140000000000001 110.93 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.88 0.372 . . . . 73.200000000000003 110.836 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.9 tpt -122.31 122.54 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.310000000000002 110.894 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.55 160.54 76.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 71.340000000000003 110.85 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.372 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 55.549999999999997 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.450000000000003 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.549999999999997 110.921 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.329999999999998 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.478 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.400000000000006 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.869 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 72.299999999999997 111.133 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.140000000000001 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.349999999999994 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -51.02 66.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.946 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.89 -30.19 23.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 63.32 111.132 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.57 26.66 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 74.239999999999995 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -86.24 155.77 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.893 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.872 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.883 0.373 . . . . 53.219999999999999 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 mtp -57.27 -40.15 77.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 72.230000000000004 110.853 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -71.4 160.6 82.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 73.450000000000003 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 63.409999999999997 112.319 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 50.5 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 74.209999999999994 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 72.420000000000002 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 70.430000000000007 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 74.239999999999995 110.891 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 111.118 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 71.439999999999998 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 73.209999999999994 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 70.319999999999993 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.92 -48.97 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.87 -30.11 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 71.140000000000001 111.113 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -65.71 146.4 54.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 74.120000000000005 110.875 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -130.94 158.41 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.895 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.898 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.859 0.361 . . . . 60.310000000000002 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 76.1 mtm -58.03 -41.97 84.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 70.209999999999994 110.871 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.39 160.59 64.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.593 0.711 . . . . 72.420000000000002 110.876 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.450000000000003 112.338 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 72.230000000000004 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.319999999999993 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 70.209999999999994 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 74.150000000000006 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.519999999999996 111.137 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.230000000000004 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.540000000000006 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.400000000000006 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -52.02 -44.6 64.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.865 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt 53.31 46.02 27.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.935 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.64 135.62 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 75.209999999999994 110.899 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.913 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.88 0.371 . . . . 74.519999999999996 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.9 110.43 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 72.209999999999994 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -69.95 160.59 79.7 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 75.409999999999997 110.82 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.239999999999995 112.343 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.540000000000006 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 75.219999999999999 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 72.109999999999999 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 75.030000000000001 111.14 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.340000000000003 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 73.040000000000006 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -51.94 -47.88 64.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.209999999999994 110.887 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.76 -31.94 28.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 75.209999999999994 111.113 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -68.58 134.8 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 75.400000000000006 110.923 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -138.51 147.4 43.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 72.439999999999998 110.918 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 73.120000000000005 110.904 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.928 0.394 . . . . 74.310000000000002 110.837 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -104.65 157.91 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 72.319999999999993 110.867 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -102.18 160.62 25.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.571 0.7 . . . . 72.540000000000006 110.893 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.200000000000003 112.371 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.329999999999998 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 75.400000000000006 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 73.209999999999994 110.899 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 72.349999999999994 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.219999999999999 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.439999999999998 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 64.340000000000003 110.87 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 75.420000000000002 111.106 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.030000000000001 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.209999999999994 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -71.88 -26.62 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.63 -32.85 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 72.019999999999996 111.057 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -66.01 166.89 10.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 73.420000000000002 110.892 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.47 150.26 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 63.520000000000003 110.886 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 110.872 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.844 0.354 . . . . 73.209999999999994 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.02 113.66 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.862 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -93.07 160.57 33.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 73.299999999999997 110.87 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 74.519999999999996 112.328 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 74.019999999999996 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 70.5 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.409 ' O ' ' C ' ' A' ' 8' ' ' LYS . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 65.120000000000005 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.409999999999997 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 75.0 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.310000000000002 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 73.540000000000006 111.102 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.420000000000002 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 72.099999999999994 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.9 -45.68 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 74.310000000000002 110.967 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.52 -29.85 27.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.504 . . . . 72.430000000000007 111.129 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -68.81 136.97 53.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 75.310000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -164.46 144.21 7.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.5 110.919 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.962 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.826 0.346 . . . . 72.420000000000002 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.1 ptm -123.85 -178.76 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.439999999999998 110.909 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.17 157.29 42.65 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.577 0.703 . . . . 64.219999999999999 110.829 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.120000000000005 112.325 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.409999999999997 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.150000000000006 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 72.109999999999999 110.927 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 75.120000000000005 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 74.409999999999997 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.409999999999997 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.111 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 72.209999999999994 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 74.430000000000007 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -71.88 -27.69 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 110.951 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.8 -26.96 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 74.340000000000003 111.109 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -81.13 87.56 6.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 73.209999999999994 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -98.43 136.95 37.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 75.209999999999994 110.89 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 75.010000000000005 110.912 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.582 0.706 . . . . 72.510000000000005 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.140000000000001 112.344 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.399999999999999 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 73.430000000000007 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 50.119999999999997 110.911 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 60.43 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.120000000000005 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.93 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.629 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 72.049999999999997 111.179 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.209999999999994 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.030000000000001 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.129999999999995 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.972 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 73.329999999999998 112.317 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.099999999999994 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 52.240000000000002 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.109999999999999 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.299999999999997 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.873 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.563 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 54.450000000000003 111.132 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.119999999999997 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 72.409999999999997 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.876 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.609 0.718 . . . . 75.329999999999998 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.530000000000001 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' HD23 ' A' ' 7' ' ' LEU . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.842 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 6' ' ' HIS . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 70.140000000000001 110.889 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 62.32 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 65.040000000000006 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 63.5 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 7' ' ' LEU . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 42.109999999999999 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.530000000000001 110.904 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.591 0.71 . . . . 61.420000000000002 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.372 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 24.140000000000001 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.450000000000003 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.549999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.478 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.400000000000006 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.869 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 62.509999999999998 111.133 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.140000000000001 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.349999999999994 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.946 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 73.450000000000003 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.319 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 33.299999999999997 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 52.25 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.200000000000003 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 51.530000000000001 110.891 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 7' ' ' LEU . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 111.118 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 70.319999999999993 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 55.329999999999998 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 64.030000000000001 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.9 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.593 0.711 . . . . 72.420000000000002 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.450000000000003 112.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 63.229999999999997 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.319999999999993 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 64.430000000000007 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 111.137 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.230000000000004 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.540000000000006 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.400000000000006 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.865 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.604 0.716 . . . . 75.409999999999997 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.669 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.239999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.540000000000006 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 52.140000000000001 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 63.200000000000003 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.643 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 74.010000000000005 111.14 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.340000000000003 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.239999999999995 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.209999999999994 110.887 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.571 0.7 . . . . 70.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.564 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.200000000000003 112.371 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.329999999999998 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 61.049999999999997 110.899 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.219999999999999 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.239999999999995 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.340000000000003 110.87 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.040000000000006 111.106 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.030000000000001 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.209999999999994 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.613 0.72 . . . . 73.299999999999997 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 70.310000000000002 112.328 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 73.120000000000005 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 65.340000000000003 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 61.310000000000002 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.409999999999997 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.310000000000002 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 7' ' ' LEU . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.420000000000002 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 65.439999999999998 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 64.420000000000002 110.967 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.577 0.703 . . . . 64.219999999999999 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.120000000000005 112.325 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.409999999999997 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.150000000000006 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 62.32 110.927 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 45.549999999999997 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.409999999999997 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 7' ' ' LEU . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.111 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 52.229999999999997 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 54.420000000000002 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 110.951 -179.911 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 74.129999999999995 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 9.1 tpt -61.51 115.99 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 75.530000000000001 110.873 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.33 160.56 54.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 72.510000000000005 110.851 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.140000000000001 112.344 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.399999999999999 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 73.430000000000007 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 50.119999999999997 110.911 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 60.43 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.120000000000005 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.109999999999999 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.340000000000003 110.93 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.629 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 72.049999999999997 111.179 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.209999999999994 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.030000000000001 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.129999999999995 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -53.61 39.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.310000000000002 110.972 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.5 48.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 74.329999999999998 111.108 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 61.14 47.62 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 70.430000000000007 110.905 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -104.93 170.33 7.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.219999999999999 110.877 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.219999999999999 110.915 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 53.149999999999999 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.3 mmm -93.44 -57.33 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 71.340000000000003 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -73.77 160.56 81.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 73.329999999999998 110.869 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 73.329999999999998 112.317 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.099999999999994 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.150000000000006 110.89 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 52.240000000000002 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.109999999999999 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.299999999999997 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.530000000000001 110.873 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.563 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 54.450000000000003 111.132 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.119999999999997 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 72.409999999999997 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.409999999999997 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -51.02 59.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.420000000000002 110.876 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HB1' ' HG3' ' A' ' 19' ' ' LYS . . . -54.46 -37.32 65.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.219999999999999 111.071 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? 57.5 27.89 14.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 63.340000000000003 110.882 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 32.3 mtpt -56.66 173.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.109999999999999 110.933 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 52.340000000000003 110.896 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 71.109999999999999 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.05 148.79 51.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 63.210000000000001 110.849 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.0 160.58 1.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.718 . . . . 75.329999999999998 110.85 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.530000000000001 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' HD23 ' A' ' 7' ' ' LEU . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.510000000000005 110.842 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 6' ' ' HIS . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 70.140000000000001 110.889 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 62.32 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 65.040000000000006 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 63.5 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 7' ' ' LEU . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 42.109999999999999 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.239999999999995 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.94 -48.23 64.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.530000000000001 110.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.9 47.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 53.219999999999999 111.083 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 130.7 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 71.329999999999998 110.933 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -104.51 153.73 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.120000000000005 110.93 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 71.219999999999999 110.93 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.88 0.372 . . . . 73.200000000000003 110.836 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.9 tpt -122.31 122.54 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.310000000000002 110.894 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.55 160.54 76.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 61.420000000000002 110.85 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.310000000000002 112.372 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 24.140000000000001 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.450000000000003 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.549999999999997 110.921 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.200000000000003 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.109999999999999 112.478 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.400000000000006 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.420000000000002 110.869 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 62.509999999999998 111.133 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.140000000000001 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.349999999999994 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.120000000000005 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -51.02 66.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.349999999999994 110.946 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.89 -30.19 23.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 42.509999999999998 111.132 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.57 26.66 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 73.209999999999994 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -86.24 155.77 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.319999999999993 110.893 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 71.409999999999997 110.872 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.883 0.373 . . . . 53.219999999999999 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 mtp -57.27 -40.15 77.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 60.149999999999999 110.853 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -71.4 160.6 82.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 73.450000000000003 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 54.310000000000002 112.319 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 33.299999999999997 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.510000000000005 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 65.129999999999995 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 52.25 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.200000000000003 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.439999999999998 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 51.530000000000001 110.891 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 7' ' ' LEU . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.120000000000005 111.118 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 70.319999999999993 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 55.329999999999998 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 64.030000000000001 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.92 -48.97 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.329999999999998 110.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.87 -30.11 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 71.140000000000001 111.113 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -65.71 146.4 54.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 70.430000000000007 110.875 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -130.94 158.41 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.519999999999996 110.895 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 75.010000000000005 110.898 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.859 0.361 . . . . 60.310000000000002 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 76.1 mtm -58.03 -41.97 84.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 64.019999999999996 110.871 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.39 160.59 64.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.593 0.711 . . . . 72.420000000000002 110.876 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.450000000000003 112.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.420000000000002 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.219999999999999 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.219999999999999 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 63.229999999999997 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.319999999999993 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 64.430000000000007 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.239999999999995 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.129999999999995 111.137 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.230000000000004 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.540000000000006 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.400000000000006 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -52.02 -44.6 64.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.239999999999995 110.865 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.420000000000002 111.103 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt 53.31 46.02 27.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.409999999999997 110.935 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.64 135.62 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 54.329999999999998 110.899 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.340000000000003 110.913 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.88 0.371 . . . . 74.519999999999996 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.9 110.43 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 71.230000000000004 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -69.95 160.59 79.7 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 75.409999999999997 110.82 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.669 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.239999999999995 112.343 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.540000000000006 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 52.140000000000001 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.540000000000006 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 63.200000000000003 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.209999999999994 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.329999999999998 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.643 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 74.010000000000005 111.14 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.340000000000003 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.239999999999995 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -51.94 -47.88 64.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.209999999999994 110.887 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.76 -31.94 28.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 61.039999999999999 111.113 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -68.58 134.8 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 75.400000000000006 110.923 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -138.51 147.4 43.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 54.520000000000003 110.918 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 73.120000000000005 110.904 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.928 0.394 . . . . 72.519999999999996 110.837 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -104.65 157.91 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 64.409999999999997 110.867 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -102.18 160.62 25.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.571 0.7 . . . . 70.0 110.893 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.200000000000003 112.371 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.329999999999998 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 72.439999999999998 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 61.049999999999997 110.899 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.209999999999994 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.219999999999999 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.239999999999995 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.340000000000003 110.87 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.040000000000006 111.106 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.030000000000001 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.209999999999994 110.879 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.439999999999998 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -71.88 -26.62 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 14' ' ' MET . . . -61.63 -32.85 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 72.019999999999996 111.057 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -66.01 166.89 10.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.209999999999994 110.892 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.47 150.26 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 44.210000000000001 110.886 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.239999999999995 110.872 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.844 0.354 . . . . 73.209999999999994 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.02 113.66 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 74.409999999999997 110.862 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -93.07 160.57 33.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 73.299999999999997 110.87 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 70.310000000000002 112.328 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 73.120000000000005 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 65.340000000000003 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 61.310000000000002 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.409999999999997 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 74.010000000000005 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.310000000000002 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.109999999999999 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 7' ' ' LEU . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.420000000000002 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 65.439999999999998 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.120000000000005 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.9 -45.68 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 64.420000000000002 110.967 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.52 -29.85 27.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.504 . . . . 72.109999999999999 111.129 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -68.81 136.97 53.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 75.310000000000002 110.906 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -164.46 144.21 7.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.5 110.919 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.420000000000002 110.962 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.826 0.346 . . . . 72.420000000000002 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.1 ptm -123.85 -178.76 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.439999999999998 110.909 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.17 157.29 42.65 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.577 0.703 . . . . 64.219999999999999 110.829 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.120000000000005 112.325 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.409999999999997 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.150000000000006 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 62.32 110.927 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.239999999999995 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 45.549999999999997 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.409999999999997 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 7' ' ' LEU . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.129999999999995 111.111 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 52.229999999999997 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 54.420000000000002 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.420000000000002 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -71.88 -27.69 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.439999999999998 110.951 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.8 -26.96 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 74.340000000000003 111.109 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -81.13 87.56 6.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.439999999999998 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -98.43 136.95 37.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 72.010000000000005 110.89 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 75.010000000000005 110.912 179.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 121.582 0.706 . . . . 72.51 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.14 112.344 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.4 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 73.43 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 50.12 110.911 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 60.43 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.12 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.11 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.93 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.629 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 72.05 111.179 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.21 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.03 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.13 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.972 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.586 0.708 . . . . 73.33 110.869 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 73.33 112.317 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.1 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.89 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 52.24 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.11 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.3 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.873 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.563 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 54.45 111.132 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.12 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 72.41 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.41 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.42 110.876 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 121.609 0.718 . . . . 75.33 110.85 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.53 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' HD23 ' A' ' 7' ' ' LEU . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.51 110.842 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 6' ' ' HIS . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 70.14 110.889 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 62.32 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 65.04 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 63.5 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 7' ' ' LEU . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 42.11 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.24 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.53 110.904 -179.925 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 121.591 0.71 . . . . 61.42 110.85 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.31 112.372 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 24.14 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.45 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.55 110.921 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.11 112.478 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.4 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.869 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 62.51 111.133 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.14 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.35 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.12 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.35 110.946 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 121.622 0.725 . . . . 73.45 110.828 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 54.31 112.319 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 33.3 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.51 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 65.13 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 52.25 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.2 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.44 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 51.53 110.891 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 7' ' ' LEU . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.118 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 70.32 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 55.33 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.33 110.9 -179.872 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--O 1.232 0.134 0 CA-C-O 121.593 0.711 . . . . 72.42 110.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.45 112.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.42 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.22 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 63.23 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.32 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 64.43 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.13 111.137 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.23 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.54 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.4 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.865 -179.886 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.604 0.716 . . . . 75.41 110.82 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.669 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.24 112.343 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.54 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 52.14 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 63.2 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.21 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.643 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 74.01 111.14 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.34 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.24 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.24 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.21 110.887 -179.891 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 121.571 0.7 . . . . 70.0 110.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.564 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.2 112.371 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.33 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 72.44 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 61.05 110.899 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.22 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.24 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.34 110.87 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.04 111.106 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.03 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.21 110.879 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 121.613 0.72 . . . . 73.3 110.87 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 70.31 112.328 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 73.12 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 65.34 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 61.31 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.41 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.31 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 7' ' ' LEU . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 65.22 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.42 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 65.44 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 64.42 110.967 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 121.577 0.703 . . . . 64.22 110.829 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.12 112.325 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.41 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.15 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 62.32 110.927 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 45.55 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.41 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 7' ' ' LEU . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.13 111.111 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 52.23 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 54.42 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.951 -179.911 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.848 0.356 . . . . 74.13 110.836 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 9.1 tpt -61.51 115.99 4.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 75.53 110.873 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -85.33 160.56 54.0 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.582 0.706 . . . . 72.51 110.851 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.75 75.11 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.686 2.258 . . . . 73.14 112.344 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.64 -31.55 7.38 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.762 -0.732 . . . . 62.4 112.49 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -73.67 -35.93 65.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.33 . . . . 73.43 110.867 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.662 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.61 -12.12 56.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 50.12 110.911 -179.976 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.82 -32.5 0.09 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 60.43 110.873 179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.41 -119.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.777 -0.725 . . . . 74.12 112.464 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 20.0 tpt85 -83.58 -34.08 25.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.802 0.334 . . . . 73.11 110.855 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.9 OUTLIER -55.09 -21.7 13.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 74.34 110.93 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.629 ' HA ' HD12 ' A' ' 7' ' ' LEU . 21.0 tt -49.5 -25.3 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 72.05 111.179 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.65 -34.53 43.84 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.735 -0.745 . . . . 72.21 112.502 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.2 mmt -80.11 -22.72 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.31 . . . . 72.03 110.83 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 13.2 t90 -50.1 -62.51 1.53 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.255 -0.429 . . . . 71.13 110.931 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -51.93 -53.61 39.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.252 -0.431 . . . . 73.31 110.972 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.28 -32.5 48.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 74.33 111.108 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 20.7 ttmt 61.14 47.62 7.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 70.43 110.905 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -104.93 170.33 7.93 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.197 -0.456 . . . . 75.22 110.877 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.195 -0.457 . . . . 71.22 110.915 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.8 t . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.848 0.356 . . . . 53.15 110.909 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 7.3 mmm -93.44 -57.33 2.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 71.34 110.845 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.4 m80 -73.77 160.56 81.73 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.586 0.708 . . . . 73.33 110.869 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.556 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.2 Cg_endo -69.78 77.21 1.09 Allowed 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.666 2.244 . . . . 73.33 112.317 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.46 -30.9 7.81 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.744 -0.741 . . . . 53.5 112.488 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -74.74 -37.5 62.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.779 0.323 . . . . 74.1 110.804 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 12' ' ' ILE . 0.9 OUTLIER -83.6 -12.08 56.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.239 -0.437 . . . . 74.15 110.89 -179.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -38.56 -32.6 0.08 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 52.24 110.887 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.0 -118.4 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.688 -0.767 . . . . 61.11 112.493 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -83.69 -34.88 24.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.78 0.324 . . . . 72.3 110.885 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.5 mp0 -54.9 -21.72 12.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.465 . . . . 74.53 110.873 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.563 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.6 tt -49.33 -25.57 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 54.45 111.132 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.57 -34.7 43.57 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.728 -0.749 . . . . 62.12 112.504 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 48.8 mmm -80.14 -22.71 41.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.729 0.299 . . . . 72.41 110.838 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.18 -62.5 1.54 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.221 -0.445 . . . . 73.41 110.904 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -51.91 -51.02 59.84 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.418 . . . . 75.42 110.876 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.466 ' HB1' ' HG3' ' A' ' 19' ' ' LYS . . . -54.46 -37.32 65.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 72.22 111.071 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? 57.5 27.89 14.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 63.34 110.882 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' HB1' ' A' ' 17' ' ' ALA . 32.3 mtpt -56.66 173.46 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.454 . . . . 74.11 110.933 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 52.34 110.896 179.951 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 N--CA 1.457 -0.078 0 CA-C-O 120.863 0.363 . . . . 71.11 110.86 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -134.05 148.79 51.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 63.21 110.849 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -52.0 160.58 1.13 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.609 0.718 . . . . 75.33 110.85 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.4 Cg_endo -69.84 76.99 1.13 Allowed 'Trans proline' 0 C--N 1.342 0.229 0 C-N-CA 122.634 2.223 . . . . 73.0 112.334 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.1 7.59 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 74.53 112.485 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.632 ' CE1' HD23 ' A' ' 7' ' ' LEU . 56.7 p-80 -74.57 -36.57 63.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.803 0.335 . . . . 74.51 110.842 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.632 HD23 ' CE1' ' A' ' 6' ' ' HIS . 1.0 OUTLIER -83.91 -12.29 55.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 70.14 110.889 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.78 -32.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.24 -0.436 . . . . 62.32 110.886 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.82 -117.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.76 -0.733 . . . . 65.04 112.497 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 13.5 ttp180 -83.84 -35.68 24.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 63.5 110.841 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -54.36 -22.08 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.449 . . . . 72.25 110.858 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.528 ' HA ' HD12 ' A' ' 7' ' ' LEU . 11.2 tt -49.45 -25.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 74.5 111.126 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.59 -34.88 44.02 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.465 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 2.7 mtt -80.25 -22.83 41.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.787 0.327 . . . . 42.11 110.91 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.6 t90 -50.33 -62.52 1.54 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.207 -0.451 . . . . 73.24 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -51.94 -48.23 64.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.258 -0.428 . . . . 74.53 110.904 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.81 -30.9 47.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 53.22 111.083 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.37 130.7 45.56 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.261 -0.427 . . . . 71.33 110.933 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -104.51 153.73 20.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 71.12 110.93 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 71.22 110.93 179.977 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.88 0.372 . . . . 73.2 110.836 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 11.9 tpt -122.31 122.54 39.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 75.31 110.894 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -68.55 160.54 76.03 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.591 0.71 . . . . 61.42 110.85 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.655 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.0 Cg_endo -69.69 72.65 1.39 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.679 2.253 . . . . 72.31 112.372 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -25.97 11.61 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.774 -0.727 . . . . 24.14 112.474 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.4 t-80 -76.29 -36.54 58.33 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.837 0.351 . . . . 74.45 110.874 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -81.9 -11.8 58.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 70.55 110.921 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 7.2 mmtm -37.9 -33.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 74.2 110.902 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' O ' HG22 ' A' ' 12' ' ' ILE . . . -62.9 -120.38 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 74.11 112.478 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 18.2 mtm180 -83.22 -32.92 26.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.802 0.334 . . . . 74.4 110.847 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -55.61 -21.41 17.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.199 -0.455 . . . . 73.42 110.869 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.6 tt -50.03 -25.07 2.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 62.51 111.133 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.82 -34.38 44.8 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.727 -0.749 . . . . 71.14 112.498 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 5.5 tpp -80.01 -22.69 42.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.714 0.293 . . . . 72.35 110.822 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.3 t90 -50.47 -62.46 1.58 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.239 -0.437 . . . . 73.12 110.938 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -54.66 -51.02 66.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.28 -0.418 . . . . 74.35 110.946 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.89 -30.19 23.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.134 -0.484 . . . . 42.51 111.132 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 55.57 26.66 9.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.215 -0.448 . . . . 73.21 110.87 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 ttpt -86.24 155.77 20.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 72.32 110.893 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 71.41 110.872 179.957 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.2 t . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.883 0.373 . . . . 53.22 110.905 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.3 mtp -57.27 -40.15 77.11 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.109 -0.496 . . . . 60.15 110.853 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.8 m-70 -71.4 160.6 82.06 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.622 0.725 . . . . 73.45 110.828 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.68 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.77 73.05 1.4 Allowed 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.705 2.27 . . . . 54.31 112.319 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.44 -26.2 11.26 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.704 -0.76 . . . . 33.3 112.505 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -76.26 -44.18 38.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.807 0.337 . . . . 74.51 110.834 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.86 -11.37 60.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.444 . . . . 65.13 110.948 179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 18.7 mtpp -37.73 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 52.25 110.934 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.78 -121.12 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 61.2 112.478 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.03 -32.14 27.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 74.44 110.881 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -55.89 -21.38 19.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 51.53 110.891 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 7' ' ' LEU . 19.4 tt -50.32 -24.94 2.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.172 -0.467 . . . . 74.12 111.118 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.94 -34.15 45.24 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 70.32 112.491 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 3.0 ttt -79.95 -22.79 42.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.765 0.317 . . . . 55.33 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.78 -62.38 1.64 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.212 -0.449 . . . . 64.03 110.891 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -51.92 -48.97 63.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.257 -0.429 . . . . 75.33 110.9 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.87 -30.11 22.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 71.14 111.113 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -65.71 146.4 54.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.196 -0.456 . . . . 70.43 110.875 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtpp -130.94 158.41 40.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 73.52 110.895 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.225 -0.443 . . . . 75.01 110.898 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.859 0.361 . . . . 60.31 110.872 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 76.1 mtm -58.03 -41.97 84.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.094 -0.503 . . . . 64.02 110.871 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -66.39 160.59 64.93 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.593 0.711 . . . . 72.42 110.876 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.694 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.7 Cg_endo -69.79 73.13 1.41 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.678 2.252 . . . . 75.45 112.338 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.4 -26.25 11.24 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.75 -0.738 . . . . 74.42 112.473 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -76.19 -44.28 38.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.869 0.366 . . . . 74.22 110.875 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.694 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.82 -11.37 60.77 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 74.22 110.912 -179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 7' ' ' LEU . 7.6 mtpm? -37.7 -33.91 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 63.23 110.867 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.84 -120.98 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.718 -0.753 . . . . 75.32 112.465 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.9 tpm_? -83.1 -32.24 26.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.778 0.323 . . . . 64.43 110.87 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.8 -21.41 19.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 72.24 110.886 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.634 ' HA ' HD12 ' A' ' 7' ' ' LEU . 16.4 tt -50.29 -24.99 2.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 72.13 111.137 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.91 -34.21 45.15 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.792 -0.718 . . . . 65.23 112.455 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 32.0 mtm -79.94 -22.79 42.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.722 0.296 . . . . 72.54 110.873 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.5 t90 -50.78 -61.47 2.19 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.4 110.928 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -52.02 -44.6 64.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.292 -0.413 . . . . 74.24 110.865 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.85 -62.11 2.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.17 -0.468 . . . . 72.42 111.103 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 19.3 ttpt 53.31 46.02 27.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.191 -0.459 . . . . 75.41 110.935 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.64 135.62 22.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.199 -0.455 . . . . 54.33 110.899 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.913 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 CA--C 1.526 0.037 0 CA-C-O 120.88 0.371 . . . . 74.52 110.855 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.9 110.43 14.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.501 . . . . 71.23 110.899 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -69.95 160.59 79.7 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.604 0.716 . . . . 75.41 110.82 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.669 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.78 73.07 1.41 Allowed 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.672 2.248 . . . . 74.24 112.343 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.43 -26.26 11.2 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.706 -0.759 . . . . 73.54 112.493 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -76.19 -44.23 38.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.822 0.344 . . . . 52.14 110.854 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -71.85 -11.43 60.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 74.31 110.903 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 7' ' ' LEU . 68.0 mttt -37.62 -33.99 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 74.54 110.863 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.79 -121.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.734 -0.746 . . . . 63.2 112.493 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -83.0 -32.3 27.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.789 0.328 . . . . 72.21 110.901 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -55.75 -21.45 18.97 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.166 -0.47 . . . . 74.33 110.894 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.643 ' HA ' HD12 ' A' ' 7' ' ' LEU . 8.0 tt -50.24 -25.03 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.482 . . . . 74.01 111.14 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.97 -34.05 45.25 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.68 -0.771 . . . . 75.34 112.534 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.2 tpt -80.03 -22.71 42.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.781 0.324 . . . . 72.24 110.893 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 10.6 t90 -50.8 -62.34 1.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 72.24 110.913 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -51.94 -47.88 64.52 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.202 -0.454 . . . . 65.21 110.887 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.76 -31.94 28.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.133 -0.485 . . . . 61.04 111.113 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -68.58 134.8 50.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 75.4 110.923 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.9 tmtt? -138.51 147.4 43.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 54.52 110.918 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 73.12 110.904 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.928 0.394 . . . . 72.52 110.837 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.9 ptt? -104.65 157.91 16.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 64.41 110.867 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -102.18 160.62 25.85 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.571 0.7 . . . . 70.0 110.893 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.564 ' HB3' HD21 ' A' ' 7' ' ' LEU . 54.1 Cg_endo -69.76 77.07 1.1 Allowed 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.679 2.253 . . . . 74.2 112.371 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.37 -30.86 7.88 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.781 -0.724 . . . . 55.33 112.52 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.3 t-160 -74.74 -37.51 62.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.82 0.343 . . . . 72.44 110.82 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.564 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.56 -12.16 56.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 61.05 110.899 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.53 -32.58 0.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 71.21 110.879 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.99 -118.39 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.765 -0.731 . . . . 55.22 112.472 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.78 -34.81 24.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.782 0.325 . . . . 72.24 110.863 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -54.96 -21.71 12.67 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 63.34 110.87 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.559 ' HA ' HD12 ' A' ' 7' ' ' LEU . 20.7 tt -49.4 -25.55 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.129 -0.487 . . . . 74.04 111.106 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.55 -34.7 43.36 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.733 -0.746 . . . . 63.03 112.471 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 17' ' ' ALA . 10.2 mmm -80.08 -22.68 41.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.744 0.307 . . . . 74.21 110.879 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 16.0 t90 -50.25 -62.56 1.51 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 73.44 110.928 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.9 p90 -71.88 -26.62 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 73.25 110.962 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB3' ' HA ' ' A' ' 14' ' ' MET . . . -61.63 -32.85 73.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.067 -0.515 . . . . 72.02 111.057 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mmpt? -66.01 166.89 10.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.234 -0.439 . . . . 72.21 110.892 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.47 150.26 49.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.451 . . . . 44.21 110.886 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 64.3 tp60 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 72.24 110.872 179.979 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 13.0 t . . . . . 0 CA--C 1.527 0.06 0 CA-C-O 120.844 0.354 . . . . 73.21 110.872 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 3.2 ttt -65.02 113.66 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.496 . . . . 74.41 110.862 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.3 m170 -93.07 160.57 33.33 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.613 0.72 . . . . 73.3 110.87 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.677 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.6 Cg_endo -69.77 75.25 1.23 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.644 2.23 . . . . 70.31 112.328 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -96.12 -24.15 15.53 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.759 -0.734 . . . . 73.12 112.488 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -76.99 -46.87 22.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 65.34 110.847 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.8 OUTLIER -69.81 -11.4 60.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 61.31 110.929 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' C ' ' O ' ' A' ' 7' ' ' LEU . 28.1 mtpt -37.52 -33.97 0.08 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.41 110.922 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -62.59 -120.62 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.749 -0.739 . . . . 74.01 112.462 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 4.7 mmt-85 -83.2 -32.6 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.823 0.344 . . . . 73.31 110.906 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -55.78 -21.36 18.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.133 -0.485 . . . . 73.11 110.89 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.619 ' HA ' HD12 ' A' ' 7' ' ' LEU . 12.2 tt -50.19 -25.04 2.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 65.22 111.102 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.99 -34.16 45.69 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.786 -0.721 . . . . 44.42 112.447 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 35.8 mmt -79.92 -22.8 42.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.759 0.314 . . . . 65.44 110.892 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 11.1 t90 -50.81 -60.76 2.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.229 -0.441 . . . . 75.12 110.933 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -51.9 -45.68 64.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 64.42 110.967 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -52.52 -29.85 27.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.09 -0.504 . . . . 72.11 111.129 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.1 tttp -68.81 136.97 53.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 75.31 110.906 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.6 tmtm? -164.46 144.21 7.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 73.5 110.919 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 71.42 110.962 179.91 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.2 m . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.826 0.346 . . . . 72.42 110.867 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 27.1 ptm -123.85 -178.76 4.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.495 . . . . 73.44 110.909 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -114.17 157.29 42.65 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.577 0.703 . . . . 64.22 110.829 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.653 ' HB3' HD21 ' A' ' 7' ' ' LEU . 53.3 Cg_endo -69.81 75.1 1.26 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.642 2.228 . . . . 75.12 112.325 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -95.7 -31.44 7.42 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 73.41 112.538 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -72.84 -36.41 67.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.819 0.342 . . . . 71.15 110.845 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.653 HD21 ' HB3' ' A' ' 4' ' ' PRO . 0.9 OUTLIER -83.47 -12.45 56.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.437 . . . . 62.32 110.927 -179.971 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -38.76 -32.62 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.192 -0.458 . . . . 74.24 110.886 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -63.51 -119.14 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.745 -0.741 . . . . 45.55 112.498 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.66 -34.1 25.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.763 0.316 . . . . 75.41 110.861 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -55.11 -21.56 13.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.888 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.642 ' HA ' HD12 ' A' ' 7' ' ' LEU . 14.0 tt -49.25 -25.53 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.153 -0.476 . . . . 71.13 111.111 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -52.67 -34.18 43.27 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 52.23 112.514 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' MET . . . . . . . . . . . . . 10.1 mtp -80.08 -22.65 42.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.753 0.311 . . . . 54.42 110.881 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 15.3 t90 -50.06 -62.64 1.46 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.227 -0.442 . . . . 74.42 110.904 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -71.88 -27.69 63.03 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.246 -0.434 . . . . 73.44 110.951 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -55.8 -26.96 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 74.34 111.109 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.2 tptt -81.13 87.56 6.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.896 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.2 mtpp -98.43 136.95 37.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.25 -0.432 . . . . 72.01 110.89 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.449 . . . . 75.01 110.912 179.95 . . . . . . . . 0 0 . 1 stop_ save_